Abstract
Mycobacterium malmoense was isolated in four different sputum samples of a 45-year-old alcoholic smoker. The biochemical and culture characteristics of this species are described and compared with a reference strain (ATCC 29571). The isolated strain was sensitive in vitro to rifampicine, ethionamide, kanamycine and erythromycin. Therapy consisted of right-upper-lobe lobectomy and a two-year antimicrobial therapy. There was no sign of relapse at the end of the treatment period.
MeSH terms
-
Bronchoalveolar Lavage Fluid / microbiology
-
Erythromycin / therapeutic use
-
Humans
-
Isoniazid / therapeutic use
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Mycobacterium / isolation & purification*
-
Mycobacterium Infections / etiology*
-
Mycobacterium Infections, Nontuberculous / etiology*
-
Mycobacterium Infections, Nontuberculous / therapy
-
Nontuberculous Mycobacteria / drug effects
-
Nontuberculous Mycobacteria / isolation & purification*
-
Pneumonectomy
-
Rifampin / therapeutic use
-
Sputum / microbiology
-
Switzerland
Substances
-
Erythromycin
-
Isoniazid
-
Rifampin